The continuing circus in Washington has pushed the Department of Justice’s civil fraud investigation of UnitedHealth’s ...

Discover why Oscar Health (OSCR) could offer 10x potential with its D2C model, AI-driven efficiencies, strong growth, and ...

We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 06th, the Representative disclosed that they ...

Investment analysts at Zacks Research increased their Q1 2025 earnings estimates for shares of UnitedHealth Group in a report released on Thursday, March 6th. Zacks Research analyst D. Chatterjee now ...

Just over a year ago, cybercriminals launched a ransomware attack on clearinghouse Change Healthcare in what became the ...

Robert F. Kennedy Jr. -- head of Health and Human Services -- says U.S. has one of the worst health comes despite spending ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

UnitedHealth acquired or created 250 subsidiaries in 2024 as it pursues an ambitious vertical integration strategy.

Crowds of people camped at the Manhattan Criminal Court in support of Luigi Mangione, the suspect behind UnitedHealthcare CEO ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Daytime television inundates American seniors with advertisements for UnitedHealthcare’s (“UHC”) Medicare Advantage Plans. On its website, UHC ...